It was reported that human epidermal growth factor receptor-2 (HER-2) amplification in G-EAC is more frequent than in other cervical adenocarcinomas, and it is more prevalent in individuals with ovarian metastases and late stage (22). The gene discussed is ERBB2; the disease is cervical adenocarcinoma.